Revinax introduces mixed reality into the OR

Virtual surgery training company Revinax has helped assist a surgical procedure by implementing mixed reality technology.

A team of surgeons performing a spinal osteosynthesis procedure used MicroSoft’s HoleLens glasses to get extra information throughout the surgery. The team was led by Dr Lonjon, a neurosurgeon from the Montpellier University Hospital in France.

When he raised his head the surgeon performing the procedure had direct access to a 3D video of a similar surgery, performed by Dr Lonjon. The surgeon was also able to consult patient imagery and have all relevant information within view.

Dr Nicolas Lonjon, said: “This is the perfect tool for any surgery. As a teaching surgeon, I can create my own tutorials to deliver them to students before and, now also, during surgery. They can use the tutorial as a reminder during the operation. The patient imagery and planning feature also avoids unnecessary distractions: we now no longer need to check these data on the computer during the operation.”

Dr Maxime Ros, neurosurgeon and co-founder of Revinax, said: “When it comes to surgery, a certain amount of “watch and learn” will always be necessary. Virtual reality and mixed reality provide new opportunities to efficiently train surgeons by giving them a direct view of the operating site. Students can now observe the entire procedure from the perspective of the performing surgeon.”

Revinax creates real-life tutorials for surgeons. The company uses 3D footage of real procedures that are recorded with Revinax equipment. The footage offers a detailed view of the surgery with is filmed from the teacher’s perspective. To access the tutorials you need a VR headset and a smartphone to download the app.

Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via:

'Revinax introduces mixed reality into the OR' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions